Olezarsen

Drug identity checked against registry records

Also recorded as AKCEA -APOCIII-LRx; AKCEA-APOCIII-LRx; ISIS 678354

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe HypertriglyceridemiaNCT05355402IONSPhase 2Completed2023-03-22Actual
A Study of Olezarsen Administered Subcutaneously to Participants With Severe HypertriglyceridemiaNCT05552326IONSPhase 3Completed2024-12-17Actual
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial Chylomicronemia Syndrome (FCS)NCT05130450IONSPhase 3Active not recruiting2028-02Estimated
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe HypertriglyceridemiaNCT05079919IONSPhase 3Completed2024-10-22Actual
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS)NCT04568434IONSPhase 3Completed2023-07-14Actual
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With VolanesorsenNCT05185843IONSPhase 3Active not recruiting2027-06Estimated
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)NCT05681351IONSPhase 3Active not recruiting2027-03Estimated
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe HypertriglyceridemiaNCT05610280IONSPhase 3Completed2024-08-08Actual
A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric ParticipantsNCT07727538IONSPhase 3Recruiting2030-08Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.